It's important to know how to navigate the reimbursement landscape when using cellular and tissue-based products (CTP) for wound care patients. In this post, COO Rylan Smith offers his insights on how to make the best decisions for your patients when using skin substitutes.
Medicare and other providers have increased scrutiny of modifier 25, and the Office of the Inspector General (OIG) has identified it as a potential area of overuse or misuse, thereby increasing the possibility of audits. Here's what you need to know.
When it comes to billing for wound care and hyperbaric oxygen therapy services, it's important to know the differences between common terms. Our Director of Denials Management explains why.
Healthcare professionals gather from across the country to share best practices and participate in an open exchange of ideas at Q1 Productions' healthcare forums. Here's a recap of the recent Semi-Annual Healthcare Financial Forum in Chicago.
Each year, CMS releases new regulations and policy changes. Our financial team offers three things all outpatient hospital wound care teams need to know.
Revenue Cycle is a fast-moving machine that requires continuous attention, and nowhere is this more apparent than in the wound center service line. Here are five tips to help wound care programs improve revenue cycle management operations in 2018.
Do you remember when there were only a few skin subs on the market? Today, there are almost three dozen of them, with many more on the way. Collectively, they are now referred to as Cellular Tissue Products, or CTP’s. As wound care nurses, we’re jacks-of-all-trades, and that includes playing an integral role in the implementation and use of CTPs.
Fall brings vibrant colors, homemade chili, championship baseball – and new CMS regulations for reimbursement! In reviewing upcoming changes for 2018, here are five takeaways that wound centers need to be aware of.
